In this randomized, controlled, multicenter, international trial, 7376 patients with moderate to very severe COPD who ... with more mild disease or those without previous exacerbations.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Depending on your FEV1 and FVC readings, your doctor will stage your COPD based on the following: The first stage is considered ... of COPD exacerbation are also common in severe COPD.

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Owing to the modest clinical benefits of these therapies, both for acute treatment of symptoms and for prevention of exacerbations ... Patients with moderate to severe COPD were recruited into ...

The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...

Even mild COPD was associated with moderate exacerbations, and patients had an increased prevalence of cardiovascular disease, depression, and anxiety.

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

We are learning more about the stability of mild asthma over time ... childhood pneumonia, or asthma-COPD overlap (ACO) reached a COPD diagnostic threshold yet maintained normal age-related ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...